Skip to content

MiMedx Group MDXG Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Vericel logo
VericelVCEL
-$5.27M+7.9%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
-$8.34M-19.2%
CorMedix logo
CorMedixCRMD
-$50.62M-17,436%
Establishment Labs logo
Establishment LabsESTA
$3.34M-17.3%
ICU Medical logo
ICU MedicalICUI
-$9.85M+72.9%
Globus Medical logo
Globus MedicalGMED
-$24.67M+13.9%

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's change in accrued liabilities?
MiMedx Group (MDXG) reported change in accrued liabilities of -$375K in Q1 2026.
How has MiMedx Group's change in accrued liabilities changed year-over-year?
MiMedx Group's change in accrued liabilities decreased by 413.7% year-over-year, from -$73K to -$375K.
What does change in accrued liabilities mean?
Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.